Drug intelligence / Profile preview

angelicin

Development stage
Preclinical
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Topical (experimental/phototherapy), Intraperitoneal (preclinical Studies)
01

Overview

Angelicin is a naturally occurring organic compound classified as an angular furanocoumarin. It is found in various plants such as those from the Apiaceae and Fabaceae families and can also be referred to as isopsoralen. Angelicin acts primarily as a photosensitizer; upon exposure to long-wave ultraviolet (UV) light (as in PUVA therapy), it forms monoadducts with DNA by binding to pyrimidine bases. This photobinding inhibits DNA replication and nucleic acid synthesis in target cells. Angelicin has been studied for its potential use in photochemotherapy for skin disorders like psoriasis and vitiligo and has shown anti-tumor activity by inhibiting tumor cell growth. Additionally, angelicin exhibits anti-inflammatory effects through inhibition of NF-κB and MAPK signaling pathways; it also demonstrates antiviral properties and can inhibit monoamine oxidase (MAO) activity in vitro[1][3][4]. Despite these activities, angelicin itself is less commonly used clinically than related compounds such as psoralen.

Other names
2H-furo[2,3-h]chromen-2-one2-furo[2,3-h][1]benzopyran-2-one523-50-2CZZ080D7BDCZZ-080D7BDCZZ 080D7BD
02

Targets

MAOB (Monoamine oxidase B)MAOA (Monoamine oxidase A)DNA

Beyond the preview

Go deeper on angelicin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on angelicin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call